Ardelyx | ARDX - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Abbott USD 9.21B 17M 2025-12
Amgen USD 5.9B 773M 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Curis USD -13.99M 7.38M 2025-06
Sanofi EUR 10.71B 1.32B 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12
Xoma USD 22.84M 1.67M 2024-09